GCA deficiency did not affect the generation of mature neutrophils in the bone marrow or immune recruitment.[31] Thus, GCA is a potential therapeutic target for age‐related diseases, metabolic disorders, and tissue regeneration. This evidence concerns the gene GCA and metabolic disease.